TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16926224

Group type: EXPERIMENTAL
Intervention: Z-100 2 microg
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Z-100 20 microg
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Z-100 40 microg
Number of subjects: 116

Group type: COMPARATOR
Intervention: Z-100
Number of subjects: 116
Study: 12667306

Group type: EXPERIMENTAL
Intervention: Chemotherapy combined with Isorel biotherapy (29 patients)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Only chemotherapy (21 patients)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Only surgery (14 patients)
Number of subjects: 64
Study: 10894870

Group type: EXPERIMENTAL
Intervention: Thalidomide 800 mg (escalated to 1,200 mg)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Thalidomide 200 mg
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 28
Study: 8662160

Group type: EXPERIMENTAL
Intervention: Contrast-enhanced computed tomography (CT)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Cine pulmonary arteriography (gold standard)
Number of subjects: 24
Study: 1465754

Group type: EXPERIMENTAL
Intervention: Inhaled bradykinin (8 mg/ml)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Vehicle placebo
Number of subjects: 10
Study: 6376959

Group type: EXPERIMENTAL
Intervention: Colloid group
Number of subjects: 27

Group type: COMPARATOR
Intervention: Crystalloid group
Number of subjects: 27
Study: 31801567

Group type: EXPERIMENTAL
Intervention: Vitamin C (1.5 g), Thiamine (100 mg), and Hydrocortisone (50 mg) given every 6 h for up to 16 doses
Number of subjects: 501

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 501
Study: 28000377

Group type: EXPERIMENTAL
Intervention: Brief family-centred care (BFCC) programme
Number of subjects: 47

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 47
Study: 27155848

Group type: COMPARATOR
Intervention: Exercise without n-3 supplementation (EX)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Exercise with n-3 supplementation (EX + n-3)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Exercise (EX)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Rest with n-3 supplementation (R + n-3)
Number of subjects: 10
Study: 24462479

Group type: EXPERIMENTAL
Intervention: 12-session 12-step facilitation therapy (TSF)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 121
Study: 23171020

Group type: EXPERIMENTAL
Intervention: Combined oral azithromycin (10 mg/kg/d) plus allopurinol (10 mg/kg/d) for two months
Number of subjects: 86

Group type: COMPARATOR
Intervention: Intramuscular Glucantime (20 mg/kg of antimony daily for 20 days)
Number of subjects: 86
Study: 20209393

Group type: COMPARATOR
Intervention: One distal locking screw
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Two distal locking screws
Number of subjects: 57
Study: 17667021

Group type: EXPERIMENTAL
Intervention: Pursed-lips breathing
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Expiratory muscle training
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control
Number of subjects: 40
Study: 15565575

Group type: EXPERIMENTAL
Intervention: DCC method for scoring estrogen receptor (ER)
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: All IHC methods for scoring ER
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: Any‐or‐none IHC method
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: PR scores
Number of subjects: 402
Study: 11883973

Group type: EXPERIMENTAL
Intervention: Pharyngeal pack inserted
Number of subjects: 62

Group type: COMPARATOR
Intervention: No pharyngeal pack inserted
Number of subjects: 62
Study: 10521861

Group type: EXPERIMENTAL
Intervention: Autoregressive models fitted using BUGS
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bayesian approach using BUGS
Number of subjects: 0
Study: 7497685

Group type: EXPERIMENTAL
Intervention: Articulating spacer with antibiotic-impregnated cement
Number of subjects: 26
Study: 1827368

Group type: EXPERIMENTAL
Intervention: Topical tetracycline (Topicycline)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: 5% benzoyl-peroxide gel
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Oral oxytetracycline (250 mg twice daily)
Number of subjects: 69
Study: 7040493

Group type: EXPERIMENTAL
Intervention: Bumetanide (1 mg, increased to a maximum of 10 mg daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Furosemide (40 mg, increased to a maximum of 400 mg daily)
Number of subjects: 0
Study: 31805932

Group type: EXPERIMENTAL
Intervention: Direct medical costs of type 2 diabetes
Number of subjects: 628

Group type: EXPERIMENTAL
Intervention: Healthcare costs for patients with complications
Number of subjects: 628

Group type: EXPERIMENTAL
Intervention: Treatment costs due to complications
Number of subjects: 628

Group type: EXPERIMENTAL
Intervention: Healthcare costs due to hospital admissions
Number of subjects: 628

Group type: EXPERIMENTAL
Intervention: Indirect costs due to absenteeism
Number of subjects: 628
Study: 27744016

Group type: EXPERIMENTAL
Intervention: Structured, individual sports program (Group B)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Ambulatory physiotherapeutical supervision (Group C)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Treatment as usual (Group A)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: All groups (A, B, C)
Number of subjects: 77
Study: 25341064

Group type: EXPERIMENTAL
Intervention: Dermatome technique with soft tissue removal
Number of subjects: 47

Group type: COMPARATOR
Intervention: Linear incision with no soft tissue reduction
Number of subjects: 47
Study: 23123494

Group type: EXPERIMENTAL
Intervention: Prototype dentifrice containing 5000ppm fluoride and 2% PVM/MA copolymers (PVD)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Colgate(®) Total Sensitive (CTS, 1100ppm fluoride)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: ProNamel(®) (PRN, 1450ppm fluoride)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Distilled water (control)
Number of subjects: 60
Study: 22075239

Group type: EXPERIMENTAL
Intervention: Signs emphasizing patient safety
Number of subjects: 2

Group type: COMPARATOR
Intervention: Signs emphasizing personal safety
Number of subjects: 2
Study: 19656022

Group type: EXPERIMENTAL
Intervention: Ridge angles <28 degrees
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Presurgical ridge angle
Number of subjects: 20
Study: 17379006

Group type: EXPERIMENTAL
Intervention: Pioglitazone (PIO)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Pioglitazone and Simvastatin (PIO/SIM)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Simvastatin (SIM)
Number of subjects: 125
Study: 15040805

Group type: EXPERIMENTAL
Intervention: verum acupuncture
Number of subjects: 900

Group type: COMPARATOR
Intervention: sham acupuncture
Number of subjects: 900

Group type: COMPARATOR
Intervention: conservative standard therapy
Number of subjects: 900
Study: 11847411

Group type: EXPERIMENTAL
Intervention: Hydroxyethylstarch (HAES steril 10%, HES)
Number of subjects: 20

Group type: COMPARATOR
Intervention: NaCl 0.9% solution
Number of subjects: 20
Study: 9751331

Group type: EXPERIMENTAL
Intervention: Percutaneous nephrostomy
Number of subjects: 42

Group type: COMPARATOR
Intervention: Retrograde ureteral catheterization
Number of subjects: 42
Study: 7946687

Group type: EXPERIMENTAL
Intervention: Iodixanol 320 mg I/ml
Number of subjects: 102

Group type: COMPARATOR
Intervention: Ioxaglate 320 mg I/ml
Number of subjects: 102
Study: 2954166

Group type: EXPERIMENTAL
Intervention: 30-minute complete back massage
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control Group (rested, no massage)
Number of subjects: 21
Study: 31809325

Group type: EXPERIMENTAL
Intervention: Intravenous open label placebo
Number of subjects: 32
Study: 29490509

Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.4 mg
Number of subjects: 494

Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.2 mg
Number of subjects: 494

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 494
Study: 27645554

Group type: EXPERIMENTAL
Intervention: Group-based memory rehabilitation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Self-help control group
Number of subjects: 20
Study: 25575640

Group type: EXPERIMENTAL
Intervention: Immunomodulating enteral nutrition formula (IEN, n = 13, Impact(®), Nestlé)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Standard enteral nutrition formula (SEN, n = 15)
Number of subjects: 28
Study: 22988905

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 257
Study: 20433733

Group type: EXPERIMENTAL
Intervention: Mechanical traction with extension-oriented treatment approach
Number of subjects: 120

Group type: COMPARATOR
Intervention: Extension-oriented treatment approach without mechanical traction
Number of subjects: 120
Study: 18352997

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (healthy controls)
Number of subjects: 23
Study: 16554199

Group type: EXPERIMENTAL
Intervention: Initial endodontic treatment
Number of subjects: 532
Study: 14598667

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine 0.05 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intrathecal saline (control group)
Number of subjects: 40
Study: 11313095

Group type: EXPERIMENTAL
Intervention: HF‐rTMS at 90% of the motor threshold on the left prefrontal cortex
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 40
Study: 9452847

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 50

Group type: COMPARATOR
Intervention: Halothane
Number of subjects: 50
Study: 7892081

Group type: EXPERIMENTAL
Intervention: Combined schedule of inactivated polio vaccine followed by two doses of live attenuated oral polio vaccine
Number of subjects: 193

Group type: COMPARATOR
Intervention: Live attenuated oral polio vaccine (three doses)
Number of subjects: 193
Study: 3258660

Group type: EXPERIMENTAL
Intervention: Conjugated polyribosyl ribitol phosphate (PRP) vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unconjugated polyribosyl ribitol phosphate (PRP) vaccine
Number of subjects: 0
Study: 30980421

Group type: EXPERIMENTAL
Intervention: Misoprostol/phenytoin gel treatment on two wounds
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Non-topically treated wounds in misoprostol/phenytoin group
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control untreated wounds
Number of subjects: 19
Study: 29131722

Group type: EXPERIMENTAL
Intervention: Congruent health message (gain vs. loss frame) with high perceived message quality
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Congruent health message (gain vs. loss frame) with low perceived message quality
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Incongruent health message (gain vs. loss frame) with high perceived message quality
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Incongruent health message (gain vs. loss frame) with low perceived message quality
Number of subjects: 109
Study: 25179488

Group type: EXPERIMENTAL
Intervention: Videoplethysmographic (VPG) signal
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Electrocardiogram (ECG) signals
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Pulse Harmonic Strength (PHS)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Automatic ECG-based measurements
Number of subjects: 11
Study: 22752659

Group type: EXPERIMENTAL
Intervention: Metabolic syndrome adults
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy adults
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study: 21555294

Group type: EXPERIMENTAL
Intervention: Automated blood pressure devices (ABPDs)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Home blood pressure device (HBPD)
Number of subjects: 99
Study: 18651881

Group type: EXPERIMENTAL
Intervention: Antenatal pelvic floor muscle training (PFMT)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 164
Study: 17032160

Group type: EXPERIMENTAL
Intervention: Manual Assisted Cognitive Treatment (MACT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 30
Study: 14667670

Group type: EXPERIMENTAL
Intervention: Minimally invasive vein harvest techniques
Number of subjects: 14

Group type: COMPARATOR
Intervention: Conventional vein harvest techniques
Number of subjects: 14
Study: 11066029

Group type: EXPERIMENTAL
Intervention: Mucolytic medication
Number of subjects: 159
Study: 9337828

Group type: EXPERIMENTAL
Intervention: Exhalation at an expiratory flow rate of 250 ml/min
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Exhalation at an expiratory flow rate of 1100 ml/min
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Water consumption (hot or cold)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Sampling from a low NO reservoir system
Number of subjects: 10
Study: 7684542

Group type: EXPERIMENTAL
Intervention: Digital rectal examination (DRE)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ejaculation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no DRE or ejaculation)
Number of subjects: 0
Study: 30626496

Group type: EXPERIMENTAL
Intervention: Massage therapy plus usual care
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual care control
Number of subjects: 60
Study: 29178728

Group type: EXPERIMENTAL
Intervention: Ultra-low abrasivity dentifrice (5% w/w KNO3, 5% w/w STP, 1,100 ppm fluoride as sodium fluoride; RDA10)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Moderate abrasivity fluoride dentifrice (1,100 ppm fluoride as sodium monofluorophosphate; RDA68)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Higher abrasivity daily-use whitening dentifrice (1,100 ppm fluoride as sodium fluoride; RDA137)
Number of subjects: 168
Study: 25711173

Group type: EXPERIMENTAL
Intervention: MMP
Number of subjects: 32

Group type: COMPARATOR
Intervention: FM/RME
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 32
Study: 24014214

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate 100 mg/day for 5 days plus uFSH 37.5 IU/day
Number of subjects: 174

Group type: COMPARATOR
Intervention: uFSH 37.5 IU/day
Number of subjects: 174
Study: 22111524

Group type: EXPERIMENTAL
Intervention: 16-hour course with interactive training for practice nurses delivered over 4 afternoons and one 1/2 hour visit to the practice over 10 months.
Number of subjects: 4034
Study: 18751491

Group type: EXPERIMENTAL
Intervention: Surgical hand antisepsis solutions (specific solutions not mentioned)
Number of subjects: 0
Study: 16021004

Group type: EXPERIMENTAL
Intervention: Group II lenses soaked in polyhexamethylene biguanide-based systems
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Silicone hydrogel lenses soaked in regimen 4
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Regimen 1 with group II lenses
Number of subjects: 0
Study: 12865477

Group type: EXPERIMENTAL
Intervention: Testosterone undecanoate (80 mg twice daily)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study: 9890362

Group type: EXPERIMENTAL
Intervention: Curriculum-plus-CYS intervention (Reach for Health Community Youth Service program)
Number of subjects: 972

Group type: COMPARATOR
Intervention: Curriculum-only intervention
Number of subjects: 972

Group type: EXPERIMENTAL
Intervention: CYS intervention
Number of subjects: 972
Study: 8694165

Group type: EXPERIMENTAL
Intervention: Syntocinon (1 ml, 10 units)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Saline (1 ml, placebo)
Number of subjects: 64
Study: 1905592

Group type: EXPERIMENTAL
Intervention: Sustained-release diltiazem 180 mg b.i.d.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 6410280

Group type: EXPERIMENTAL
Intervention: Counseling plus supportive‐expressive psychotherapy (SE)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Counseling plus cognitive‐behavioral psychotherapy (CB)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Drug counseling alone (DC)
Number of subjects: 110
Study: 31039600

Group type: EXPERIMENTAL
Intervention: Gold AQ (Sinocare)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Freestyle Optium Xceed (Abbott)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Contour TS (Bayer)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: OneTouch Ultra (J&J)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Accu‐Chek Performa (Roche)
Number of subjects: 120
Study: 31868694

Group type: EXPERIMENTAL
Intervention: Horse-riding therapy (H-RT)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Rhythm and music-based therapy (R-MT)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 123
Study: 29311155

Group type: EXPERIMENTAL
Intervention: Sitagliptin therapy
Number of subjects: 14671

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14671

Group type: EXPERIMENTAL
Intervention: SHEs
Number of subjects: 14671

Group type: EXPERIMENTAL
Intervention: Nonfatal myocardial infarction
Number of subjects: 14671

Group type: EXPERIMENTAL
Intervention: Nonfatal stroke
Number of subjects: 14671

Group type: EXPERIMENTAL
Intervention: hHF
Number of subjects: 14671
Study: 27095003

Group type: EXPERIMENTAL
Intervention: Human α1-antitrypsin (A1AT) 240 mg/kg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Human albumin
Number of subjects: 10
Study: 23846354

Group type: EXPERIMENTAL
Intervention: Daclizumab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Daclizumab variant (lacking FcR binding)
Number of subjects: 0
Study: 22170862

Group type: EXPERIMENTAL
Intervention: Fetal endoscopic tracheal occlusion (FETO)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Standard postnatal management (Control)
Number of subjects: 41
Study: 19786415

Group type: EXPERIMENTAL
Intervention: Escitalopram during intravenous interferon-alpha therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Methylphenidate during intravenous interferon-alpha therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Escitalopram and methylphenidate together during subcutaneous interferon therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Alternate agent alone during subcutaneous interferon therapy
Number of subjects: 0
Study: 17514589

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (submaximal exercise on bicycle ergometer, increasing work loads of 1.5, 2.0 and 2.5 W/kg, total duration 20 min)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hyperthermia (sauna at 80 degrees C for 30 min)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hypoglycemia (induced by insulin 0.1 IU/kg intravenously)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Apomorphine (0.75 mg subcutaneously)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hypoglycemia (after previous treatment with apomorphine)
Number of subjects: 0
Study: 15646604

Group type: EXPERIMENTAL
Intervention: Caulk IRM (Dentsply Caulk, Milford, Del.) (Group I, n = 38)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: IRM base with glass ionomer core (Fuji IX GP, GC America, Alsip, Ill.) (Group II, n = 35)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Caulk IRM (Group I)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: IRM base with glass ionomer core (Group II)
Number of subjects: 73
Study: 11454118

Group type: EXPERIMENTAL
Intervention: Educational program on geriatrics
Number of subjects: 203

Group type: COMPARATOR
Intervention: Comparison group of nonintervention students
Number of subjects: 203
Study: 9744216

Group type: EXPERIMENTAL
Intervention: Training staff in a protocol for identification and acute management of abused women
Number of subjects: 8051

Group type: COMPARATOR
Intervention: Comparison site (no intervention)
Number of subjects: 8051
Study: 8092114

Group type: EXPERIMENTAL
Intervention: Lorazepam, dexamethasone, and promethazine
Number of subjects: 99

Group type: COMPARATOR
Intervention: Dexamethasone and promethazine
Number of subjects: 99
Study: 3054343

Group type: EXPERIMENTAL
Intervention: Intrathecal papaverine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional techniques
Number of subjects: 30
Study: 31651251

Group type: EXPERIMENTAL
Intervention: Partnering with Parents practice support system (10-week intervention)
Number of subjects: 420

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 420
Study: 28097625

Group type: EXPERIMENTAL
Intervention: Web-based intervention providing tailored and personalized risk information
Number of subjects: 0

Group type: COMPARATOR
Intervention: Delayed intervention control group
Number of subjects: 0
Study: 26596360

Group type: EXPERIMENTAL
Intervention: Cone beam computed tomography (CBCT) prior to third molar surgery
Number of subjects: 268

Group type: COMPARATOR
Intervention: Panoramic radiography (PR)
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: CBCT
Number of subjects: 268

Group type: COMPARATOR
Intervention: PR
Number of subjects: 268
Study: 23768675

Group type: EXPERIMENTAL
Intervention: telehealth-PST
Number of subjects: 121
Study: 21480374

Group type: EXPERIMENTAL
Intervention: Active rTMS
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 10
Study: 19348328

Group type: EXPERIMENTAL
Intervention: Curosurf administration
Number of subjects: 0
Study: 16957969

Group type: EXPERIMENTAL
Intervention: Intradermal (ID) injection of 99mTc-sulfur colloid
Number of subjects: 400

Group type: COMPARATOR
Intervention: Intraparenchymal (IP) injection of 99mTc-sulfur colloid
Number of subjects: 400

Group type: COMPARATOR
Intervention: Subareolar (SA) injection of 99mTc-sulfur colloid
Number of subjects: 400
Study: 12818977

Group type: EXPERIMENTAL
Intervention: Increasing the magnitude of lateral table tilt
Number of subjects: 0

Group type: COMPARATOR
Intervention: Extremes of lateral table tilt
Number of subjects: 0
Study: 10831163

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment (0.125 IU/kg/wk for 4 weeks, then 0.25 IU/kg/wk for 6 months)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 8633697

Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 39

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 39
Study: 1638179

Group type: EXPERIMENTAL
Intervention: Zinc sulphate supplementation in 15 patients with compensated cirrhosis
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cirrhotic patients (all groups)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cirrhotic patients
Number of subjects: 60